PATENT CLAIM ANALYSIS

Application Number: 16237017
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["514", "215000"]

Abstract:
Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.

Claim (Index 86):
The method of  claim 85 , wherein the disease, disorder or condition in a mammal is selected from nonalcoholic steatohepatitis (NASH), hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, dyslipidemia, lipodystrophy, atherosclerosis, atherosclerotic disease, atherosclerotic disease events, atherosclerotic cardiovascular disease, Syndrome X, diabetes mellitus, type II diabetes, insulin insensitivity, hyperglycemia, cholestasis and obesity.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 98.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15630189', '15599647', '15714013', '15024681', '15546165']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7832824496996574
- 35 USC 102 Novelty (BERT): 0.5791154746799596
- Combined Prediction Score: 0.7628657521976877
- Mean Citation Score: 385.994132
- Max Citation Score: 479.6023
- Similarity Product: 381.3345204125643

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test